Lowest-Rated StocksLowest-RatedNASDAQ:FTRE Fortrea (FTRE) Stock Price, News & Analysis $4.18 0.00 (0.00%) Closing price 04:00 PM EasternExtended Trading$4.18 0.00 (-0.12%) As of 04:24 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Fortrea Stock (NASDAQ:FTRE) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Fortrea alerts:Sign Up Key Stats Today's Range$3.97▼$4.2050-Day Range$4.06▼$9.4052-Week Range$3.98▼$28.41Volume1.69 million shsAverage Volume1.80 million shsMarket Capitalization$378.29 millionP/E RatioN/ADividend YieldN/APrice Target$15.00Consensus RatingReduce Company OverviewFortrea Holdings Inc., a contract research organization, primarily engages in the provision of biopharmaceutical product and medical device development services worldwide. The company operates through two segments: Clinical Services and Enabling Services. The Clinical Services segment provides across the clinical pharmacology and clinical development spectrum. The Enabling Services segment provides patient access and clinical trial technology solutions to customers that streamline complex randomization and optimize the trial drug supply process. The company offers delivery models that include full service, functional service provider, and hybrid service structures. It also offers phase I-IV clinical trial management, differentiated technology enabled trial solutions, and post approval services, as well as consulting services. The company serves pharmaceutical, biotechnology, and medical device organizations. Fortrea Holdings Inc. was incorporated in 2023 and is headquartered in Durham, North Carolina.Read More… Fortrea Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks61st Percentile Overall ScoreFTRE MarketRank™: Fortrea scored higher than 61% of companies evaluated by MarketBeat, and ranked 415th out of 933 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.9 / 5Analyst RatingReduce Consensus RatingFortrea has received a consensus rating of Reduce. The company's average rating score is 1.86, and is based on no buy ratings, 12 hold ratings, and 2 sell ratings.Amount of Analyst CoverageFortrea has been the subject of 8 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Fortrea's stock forecast and price target. Earnings and Valuation2.5 / 5Proj. Earnings Growth150.98% Earnings GrowthEarnings for Fortrea are expected to grow by 150.98% in the coming year, from $0.51 to $1.28 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Fortrea is -1.22, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Fortrea is -1.22, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Growth RatioFortrea has a PEG Ratio of 1.78. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioFortrea has a P/B Ratio of 0.21. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about Fortrea's valuation and earnings. Short Interest1.0 / 5Short Interest LevelBearish Percentage of Shares Shorted13.66% of the float of Fortrea has been sold short.Short Interest Ratio / Days to CoverFortrea has a short interest ratio ("days to cover") of 4.1.Change versus previous monthShort interest in Fortrea has recently increased by 48.67%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldFortrea does not currently pay a dividend.Dividend GrowthFortrea does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted13.66% of the float of Fortrea has been sold short.Short Interest Ratio / Days to CoverFortrea has a short interest ratio ("days to cover") of 4.1.Change versus previous monthShort interest in Fortrea has recently increased by 48.67%, indicating that investor sentiment is decreasing significantly. News and Social Media2.1 / 5News Sentiment0.86 News SentimentFortrea has a news sentiment score of 0.86. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.News Coverage This WeekMarketBeat has tracked 5 news articles for Fortrea this week, compared to 6 articles on an average week.Search Interest1 people have searched for FTRE on MarketBeat in the last 30 days. Company Ownership0.8 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Fortrea insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $6,417.00 in company stock.Percentage Held by InsidersOnly 0.12% of the stock of Fortrea is held by insiders.Read more about Fortrea's insider trading history. Receive FTRE Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Fortrea and its competitors with MarketBeat's FREE daily newsletter. Email Address FTRE Stock News HeadlinesFTRE stock touches 52-week low at $4.01 amid sharp annual declineMay 25, 2025 | uk.investing.comFortrea Holdings Inc. (NASDAQ:FTRE) Receives $15.00 Consensus PT from AnalystsMay 22, 2025 | americanbankingnews.comWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon bring Elon Musk's DOGE operation to its final, dramatic conclusion - with huge consequences for millions of investors. So if you have any money in the market... you're almost out of time to prepare. This plan has already been put in place... and can operate even if Elon's long gone from Washington. May 29, 2025 | Altimetry (Ad)Financial Analysis: OpGen (NASDAQ:OPGN) versus Fortrea (NASDAQ:FTRE)May 20, 2025 | americanbankingnews.comFortrea Holdings Inc (FTRE) Q1 2025 Earnings Call Highlights: Navigating Challenges with ...May 14, 2025 | uk.finance.yahoo.comFortrea Announces Leadership Transition: Thomas Pike Steps Down as CEO, Peter M. Neupert Appointed Interim CEO and Board ChairMay 14, 2025 | nasdaq.comBeyond The Numbers: 6 Analysts Discuss Fortrea Holdings StockMay 14, 2025 | benzinga.comSecurities Fraud Investigation Into Fortrea Holdings Inc. ...May 12, 2025 | gurufocus.comSee More Headlines FTRE Stock Analysis - Frequently Asked Questions How have FTRE shares performed this year? Fortrea's stock was trading at $18.65 at the beginning of the year. Since then, FTRE stock has decreased by 77.6% and is now trading at $4.18. View the best growth stocks for 2025 here. How were Fortrea's earnings last quarter? Fortrea Holdings Inc. (NASDAQ:FTRE) announced its quarterly earnings results on Monday, May, 12th. The company reported $0.02 EPS for the quarter, topping analysts' consensus estimates of ($0.07) by $0.09. The business earned $651.30 million during the quarter, compared to the consensus estimate of $609.63 million. Fortrea had a positive trailing twelve-month return on equity of 2.00% and a negative net margin of 10.99%. Read the conference call transcript. Who are Fortrea's major shareholders? Fortrea's top institutional shareholders include Vanguard Group Inc. (10.99%), Sessa Capital IM L.P. (5.18%), Corvex Management LP (4.94%) and Millennium Management LLC (3.86%). Insiders that own company stock include Thomas Pike, Jill G Mcconnell and Peter M Neupert. View institutional ownership trends. How do I buy shares of Fortrea? Shares of FTRE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Fortrea own? Based on aggregate information from My MarketBeat watchlists, some other companies that Fortrea investors own include AUO (AUOTY), Waste Connections (WCN), American Water Works (AWK), The RMR Group (RMR), DiamondRock Hospitality (DRH), iShares Micro-Cap ETF (IWC) and Triple Flag Precious Metals (TFPM). Company Calendar Last Earnings5/12/2025Today5/29/2025Next Earnings (Estimated)8/11/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Medical laboratories Sub-IndustryHealthcare Current SymbolNASDAQ:FTRE CIK1965040 Webwww.fortrea.com Phone877-495-0816FaxN/AEmployees18,000Year FoundedN/APrice Target and Rating Average Stock Price Target$15.00 High Stock Price Target$25.00 Low Stock Price Target$5.00 Potential Upside/Downside+258.9%Consensus RatingReduce Rating Score (0-4)1.86 Research Coverage14 Analysts Profitability EPS (Most Recent Fiscal Year)($8.79) Trailing P/E RatioN/A Forward P/E Ratio8.20 P/E Growth1.78Net Income-$3.40 million Net Margins-10.99% Pretax Margin-8.04% Return on Equity2.00% Return on Assets0.80% Debt Debt-to-Equity Ratio0.74 Current Ratio1.18 Quick Ratio1.18 Sales & Book Value Annual Sales$2.69 billion Price / Sales0.14 Cash Flow$0.67 per share Price / Cash Flow6.28 Book Value$19.58 per share Price / Book0.21Miscellaneous Outstanding Shares90,500,000Free Float89,592,000Market Cap$378.29 million OptionableOptionable Beta2.15 These 7 Stocks Will Be Magnificent in 2025Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free Report This page (NASDAQ:FTRE) was last updated on 5/29/2025 by MarketBeat.com Staff From Our PartnersWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredTrump Exec Order 14179 is wealth “gift” to good Americans?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredMan who predicted $100K Bitcoin sees a huge run coming for another coin …Sure enough, Bitcoin took off on the exact day Juan said it would. It's up more than 40% since the election...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Fortrea Holdings Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Fortrea With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.